Multisensorial IMmersive Experiences (MIME) in Disorders of Consciousness (MIME)
Disorder of Consciousness, Acquired Brain Injury
About this trial
This is an interventional treatment trial for Disorder of Consciousness focused on measuring Disorder of Consciousness, Acquired Brain Injury, Sensory stimulation
Eligibility Criteria
Inclusion Criteria: Age between 18 and 90 years Patients who have been in a coma state and have alterations in consciousness Patients who are not responsive to rehabilitative treatment of disorders of consciousness, such as environmental stimulation, non-invasive brain stimulation, or drug treatment. Clinical stability Ability of caregiver/legal guardian to understand and sign informed consent Exclusion Criteria: Taking medications that interfere with membrane conductivity (e.g., calcium channel blockers, antiepileptic drugs). Psychiatric or other medical conditions Failure to sign informed consent The presence of a history of epilepsy and/or taking antiepileptic therapy is an exclusion criterion for assignment to the MIME+tDCS group.
Sites / Locations
- Fondazione Policlinico Universitario A. Gemelli IRCCS
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
MIME Group
MIME + tDCS Group
Stimulation with MIME will be performed in a large ad hoc room in which video images will be projected on three walls. The patient will be positioned in the center of the room, 3 meters from the front wall, with the back of the bed tilted at a 45-degree angle, so as to obtain a truly immersive view covering the entire 220-degree field of view. Audio stimulation will be achieved through two speakers located at the sides of the room, with the low frequencies reinforced by a subwoofer. The average sound intensity recorded from the patient's position will be 81 db average (maximum 87, minimum 69). Patients will undergo treatment with MIME once a day for five consecutive days, for a total of two weeks (10 sessions), in addition to conventional treatment.
Simultaneously with MIME treatment, patients will undergo transcranial direct current stimulation (tDCS). Stimulation with tDCS will begin 5 minutes after the start of resting phase 1, and the electrodes will be placed as follows: the 5×4 anode (about 20 cm2) will be placed on the left dorsolateral prefrontal area; the reference electrode, 6x5 (about 30 cm2), will instead be placed on the upper arm, specifically at the level of the right deltoid muscle, contralateral to the active electrode. Current will be applied at an intensity of 2 mA, for 20 minutes a day for 2 weeks, five days a week, for a total of 10 sessions. The current density will be kept below the safe limits reported in the literature.